At the ESCRS Winter Meeting 2025, Prof. Farhad Hafezi and Dr. Emilio Torres-Netto presented research on corneal cross-linking (CXL), including high-fluence protocols, keratoconus management, and biomechanical assessments.
Intracorneal ring segments (ICRS) can offer significant corneal flattening and vision rehabilitation effects in suitable corneas. This article explores the differences between different ring segments, and the latest advances in ICRS like Femto-CAIRS.
Dual chromophore PACK-CXL treatment using riboflavin/UV-A and rose bengal/green light may offer an effective solution for refractory Acanthamoeba keratitis.
Our latest review on corneal cross-linking (CXL), published in Progress in Retinal and Eye Research, explores its evolution, advanced protocols like ELZA-PACE, and clinical applications.
In a recent feature, Ocular Surgery News (OSN) provided an in-depth overview of the latest advancements in epi-on crosslinking, as presented by Prof. Farhad Hafezi of the ELZA Institute at the Winter ESCRS meeting in Frankfurt, Germany.
Epi-On Cross-Linking goes office-based! ELZA’s innovation eliminates bulky equipment, offering streamlined keratoconus care, tells Farhad Hafezi to Ocular Surgery News.
Central Asian University (CAU) recently hosted a highly anticipated guest lecture on “Enterprising Ophthalmology,” featuring ELZA’s CEO and CMO, Nikki and Farhad Hafezi.
Exploring comprehensive keratoconus treatment, from cross-linking to surgery, in the highly respected scientific journal Nature Reviews.
Corneal Physician reports on ELZA’s exploration of slit-lamp CXL as a promising, accessible treatment for infectious keratitis.
Prof. Farhad Hafezi from the ELZA Institute provided an insightful update on the Second Global Consensus on Keratoconus during an interview with EyeTube.
